Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DePuy Synthes Builds Out Trauma Offering With TRS' 3D-Printed Tech

Executive Summary

Underlining its focus on 3D-printing and the potential this technology can bring, DePuy Synthes has acquired the 3D-printed scaffold platform of Tissue Regeneration Systems, enabling the orthopedics leader to develop patient-specific trauma products in-house.

You may also be interested in...



M&A Analysis: April Showers Big Name Acquisitions

M&A deals rained down in April with the highest number of acquisitions of the year to date. The month saw 14 M&A deals, up by four from March's total, but still down from the 16 deals recorded in April 2016.

J&J Taps Aspect Biosystem's 3D Printing Tech For Meniscus Implant

3D bioprinting and tissue engineering specialist Aspect Biosystems has entered a research collaboration with Johnson & Johnson's DePuy Synthes to create bioprinted knee meniscus tissue suitable for surgical therapy. It is one of more than 50 commercial and academic partnerships J&J has entered to develop complementary technologies and materials for its medical devices.

J&J Announces New Device Collaborations

The Johnson & Johnson Innovation Center projects include a focus on solid-tumor resections, knee replacement procedures and atrial fibrillation ablation – as well as tracking down biomarkers tied to diabetes and prostate cancer.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT104745

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel